Cash Flow Statement
Growth Metrics

Biolife Solutions (BLFS) Change in Accured Expenses (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Change in Accured Expenses for 16 consecutive years, with $264000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses fell 16.46% to $264000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $264000.0 through Dec 2025, up 202.33% year-over-year, with the annual reading at $264000.0 for FY2025, 202.33% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was $264000.0 at Biolife Solutions, down from $3.4 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $3.4 million in Q3 2025, with the low at -$3.4 million in Q2 2025.
  • Average Change in Accured Expenses over 5 years is -$21500.0, with a median of $29500.0 recorded in 2023.
  • Peak annual rise in Change in Accured Expenses hit 5853.49% in 2024, while the deepest fall reached 14025.0% in 2024.
  • Over 5 years, Change in Accured Expenses stood at $2.3 million in 2021, then tumbled by 130.61% to -$704000.0 in 2022, then surged by 354.12% to $1.8 million in 2023, then tumbled by 82.34% to $316000.0 in 2024, then dropped by 16.46% to $264000.0 in 2025.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at $264000.0, $3.4 million, and -$3.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.